Juan Arriaga, PhD
img_Juan Arriaga
ASSISTANT PROFESSOR | Oncological Sciences
For more information visit our lab website:
Functional Identification of Therapeutic Vulnerabilities in mCRPC
We use unbiased, in vivo and genome-wide CRISPR screening approaches to indentify therapeutic vulnerabilities of the most aggressive, currently incurable prostate tumors.
Epigenetic drivers of Prostate Cancer Bone Metastasis
We study how particular epigenetic modifiers can impact prostate cancer development and progression to bone metastasis, as well as how they might influence resistance to standard of care and experimental therapies.

Bachelor's, University of Buenos Aires

PhD, University of Buenos Aires

Postdoctoral training, Columbia University


NCI K22 Career Development Award to Promote Diversity


Young Investigator Award, Prostate Cancer Foundation


Dean’s Precision Medicine Research Fellowship, Columbia University


Irving Institute Clinical Trials Office Pilot Award, Columbia University


Postdoctoral Training Award, Department of Defense


René Barón Foundation Award in Medical Sciences, National Academy of Medicine, Argentina


CONICET Predoctoral fellowship, Ministry of Science, Argentina

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Arriaga did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.